Smart Publications

Clarifying the Complex World of Nutrition Science

  • Email this article
  • Print this article
  • A
  • A
  • A

The Facts About Growth Hormone and How to Increase Your GH Levels!

Unfortunately, these subsequent researchers used arginine hydrochloride and NOT arginine pyroglutamate, which was used with great results in the original study in 1981. This is disappointing, as it had been known since 1977 that the specific chelate of arginine and pyroglutamic acid (arginine pyroglutamate) had effects on the body that are not shared by arginine or pyroglutamic acid when taken individually or together.21

No nutritional supplement has shown equivalent results to the combination of arginine pyroglutamate and lysine for releasing significant amounts of biologically active GH when taken orally in small doses. Interestingly, when both arginine pyroglutamate and lysine are taken individually, even in large doses, they are not effective.16 It is the specific combination of arginine pyroglutamate and lysine, taken in the proper ratio, which makes a very effective GH releaser.

Because of these promising initial results, the combination of APG/Lysine was developed as a pharmaceutical in Italy. Further research showed that it could enhance immune function dramatically both in healthy elderly people, and in cancer patients.222324 Notably, this combination of APG/Lysine was shown to improve immune function by increasing thymus hormone levels. This is an effect you would expect from growth hormone release, as growth hormone is known to enhance functioning of the thymus—the master gland of immunity.252627

People get better results by using GH less often than every day, or just two or three times a week.

If you decide to take a GH releaser

Too much of a good thing can be as bad for you as not enough, and this holds true for GH. Like most hormones, it is the proper dose and timing that gives the most beneficial results. In the case of GH, research has shown that there are significant differences in the effects of GH depending on how often you take it and/or how often it is released.

It's best NOT to take a GH supplement every day. Here's why:

A decade ago, it was discovered that many children who were given GH replacement to enhance their growth suffered from a GH tolerance and withdrawal syndrome that resembles the tolerance one develops when he or she takes hormones like cortisone and testosterone.28 Specifically, when children stop getting GH supplementation, they stop growing, which becomes even more of an issue than the short stature they dealt with before they started taking GH. Initially, scientists thought this was a result of the GH injections suppressing the body's normal production of GH.

Similar hormone suppression is often seen with cortisone and testosterone therapy, where it often takes months for the body to begin normal production of its own hormones after stopping the cortisone or testosterone. Surprisingly, this was not found to be true for GH. After stopping GH injections, the body rapidly resumes its normal production of GH. Yet, the tissue's response to the normal GH levels was found to be markedly diminished.28 Scientists now believe that this is because the body becomes tolerant to GH from the daily supraphysiological levels of GH caused by the GH injections.

Obviously, this is a huge drawback to using GH replacement therapy. Because as soon as we stopped taking the GH supplement, we would be in even worse shape because we would be resistant to our own GH. Luckily, research has shown that the key to preventing these problems is to not use GH on a daily basis.

In research on short children receiving GH, it was shown that by using GH every other day rather than every day the tolerance and dependence syndrome could be completely prevented.29 It seems that allowing the body a one day break in between GH use allows the tissues to remain sensitive to both its own GH and the GH supplementation. Interestingly, the same is known to be true for cortisone which is often given in an "every other day regimen" to prevent tolerance and dependence. What is troubling, though, is that many short, but otherwise normal children are given GH replacement therapy in the hope that they will grow taller, and many of them are receiving GH every day which in the long-term is likely counterproductive.

In research on adults, using GH two or three times a week has proven to be as effective as using GH every day.30 This makes the rationale of using GH daily questionable—because it is much more likely to not give optimal long-term results. Typically, the companies that market pharmaceutical GH and GH releasing supplements don't inform doctors or consumers of this fact because obviously they would sell much less product. This is in spite of the research showing that people will get better and safer results by using GH less often than every day.31

Uridine and Growth Hormone?

Uridine is a natural nucleic acid that plays a major role in neurotransmitter function, as well as helping to build membrane phospholipids and promoting neurite growth from brain cells.35 Research has shown that uridine (especially when combined with choline) can support the production and function of both acetylcholine and dopamine, two major neurotransmitters involved in growth hormone release. The decreased activity of these neurotransmitters is believed to be responsible for the age-related decline in natural growth hormone release. It is thought that uridine and choline support these neurotransmitters through the enhanced maintenance of brain cell membranes, as well as direct stimulation of neurotransmitter release. By helping to promote the optimum functioning of brain cells, uridine primes our brain for enhanced growth hormone release.

Is GH supplementation safe?

Although when used according to directions, GH has been shown to be very safe. It should not be used by people with diabetes or cancer unless they are under the care of a physician. For best results, please follow the usage suggestions below.
There are no contraindications with other drugs or supplements. And if you decide to stop taking growth hormone releaser after you start, proper dosing will assure you will not experience any negative effects. Your pituitary gland will most likely, however, start producing the amount of growth hormone it did before you took it … and if you are a senior, that means it will produce very little.

How much should you take?

The good news is that you don't need to take a GH releaser every day for great results. In research on adults, it has been shown that people will get better results by using GH less often than every day,31 or just two or three times a week.32 However, a minimum of 2 grams of the APG/ Lysine combination should be taken at one time to stimulate growth hormone.

Conclusion

The alternative to GH injections

Convenient and much more affordable than $10,000 per year GH injections—not to mention less painful—a GH releaser is a safe way for athletes to improve their peak performance, as well as for anyone wanting to help prevent cardiovascular disease, improve muscular strength and immunity, and overall health and appearance. The important thing is to make sure you buy a high quality GH releaser with the clinically proven combination of arginine pyroglutamate and lysine. 

Page 3 of 3 pages  < 1 2 3

Editor's Note:

The natural health solutions described in this article are available through many on-line retailers including those listed below. By clicking these links you help support the important alternative health research we provide.

Visit www.amazon.com – a great way to find competitive deals on supplements offered by many different manufacturers.

Visit www.hfn-usa.com – when commitment to quality and freshness is important, this factory direct solution is preferred by many of our readers.

This article is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a physician before embarking on a dietary supplement program.

References

  1. Jorgensen JO, Muller J, Moller J, et al. Adult growth hormone deficiency. Horm Res. 1994;42(4-5):235-41.

  2. Cook DM, Ludlam WH, Cook MB. The adult growth hormone deficiency syndrome. Adv Intern Med. 2000;45:297-315.

  3. Hoffman AR. Treatment of the adult growth hormone deficiency syndrome: Directions for future research. Growth Horm IGF Res. 2005 Jul;15 Suppl A:48-52.

  4. Bartke A. Minireview: role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology. 2005 Sep;146(9):3718-23.

  5. Yamaza H, Komatsu T, Chiba T, et al. A transgenic dwarf rat model as a tool for the study of calorie restriction and aging. Exp Gerontol. 2004 Feb;39(2):269-72.

  6. Besson A, Salemi S, Gallati S, et al. Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab. 2003 Aug;88(8):3664-7.

  7. Colao A, Di Somma C, Rota F, Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency. J Clin Endocrinol Metab. 2005 Apr;90(4):2056-62.

  8. Koenig W. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol. 2005 Feb 15;98(2):199-206.

  9. Woelfle J, Chia DJ, Massart-Schlesinger MB, et al. Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system. Pediatr Nephrol. 2005 Mar;20(3):295-302.

  10. Frystyk J. Free insulin-like growth factors—measurements and relationships to growth hormone secretion and glucose homeostasis.Growth Horm IGF Res. 2004 Oct;14(5):337-75.

  11. Greenspan FS, Li CH, et al. Bioassay of hypophyseal growth hormone; the tibia test. Endocrinology. 1949 Nov;45(5):455-63.

  12. de Jongh SE, Paesi FJ, van Wieringen G. The influence of growth hormone on the growth of the skeleton and soft tissues of the body.Arch Int Pharmacodyn Ther. 1950 Apr 15;82(2):148-54.

  13. Lewis RA, Klein R, Wilkins L. The effect of pituitary growth hormone in dwarfism with osseous retardation and hypoglycemia and in a cretin treated with thyroid. J Clin Invest. 1950 Apr;29(4):460-4.

  14. Cronin MJ. Pioneering recombinant growth hormone manufacturing: pounds produced per mile of height. J Pediatr. 1997 Jul;131(1 Pt 2):S5.

  15. Chromiak JA, Antonio J. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition. 2002 Jul-Aug;18(7-8):657-61.

  16. Isidori A, Lo Monaco A, Cappa M. A study of growth hormone release in man after oral administration of amino acids. Curr Med Res Opin. 1981;7(7):475-81.

  17. Suminski RR, Robertson RJ, Goss, FL, et al. Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentration in young men. Int J Sport Nutr. 1997 Mar;7(1):48-60.

  18. Lambert MI, Hefer JA, Millar RP, et al. Failure of commercial oral amino acid supplements to increase serum growth hormone concentrations in male body-builders. Int J Sport Nutr. 1993 Sep;3(3):298-305.

  19.  Fogelholm GH, Naveri HK, Kiilavuori KT, et al. Low-dose amino acid supplementation: no effects on serum human growth hormone and insulin in male weightlifters. Int J Sport Nutr. 1993 Sep;3(3):290-7.

  20. Corpas E, Blackman MR, Roberson R, et al. Oral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old men. J Gerontol. 1993 Jul;48(4):M128-33.

  21. Provenzano PM, Brucato A, GianguzzaS, et al. Chemistry and pharmacology of arginine pyroglutamate. Analysis of its effects on the CNS. Arzneimittelforschung. 1977;27(8):1553-7.

  22. Mocchegiani E, Cacciatore L, Talarico M, et al. Recovery of low thymic hormone levels in cancer patients by lysine-arginine combination. Int J Immunopharmacol. 1990;12(4):365-71.

  23. Fabris N, Mocchegiani E. Arginine-containing compounds and thymic endocrine activity. Thymus. 1992;19 Suppl 1:S21-30.

  24. Fabris N, Mocchegiani E, Muzzioli M, et al. Recovery of age-related decline of thymic endocrine activity and PHA response by lysin-arginine combination. Int J Immunopharmacol. 1986;8(7):677-85.

  25. Mocchegiani E, Paolucci P, Balsamo A, et al. Influence of growth hormone on thymic endocrine activity in humans. Horm Res. 1990;33(6):248-55.

  26. Fahy GM. Apparent induction of partial thymic regeneration in a normal human subject: a case report. J Anti Aging Med. 2003;6(3):219-27.

  27. Savino W, Postel-Vinay MC, Smaniotto S, et al. The thymus gland: a target organ for growth hormone. Scand J Immunol. 2002 May;55(5):442-52.

  28. Lampit M, Lorber A, Vilkas DL, et al. GH dependence and GH withdrawal syndrome in GH treatment of short normal children: evidence from growth and cardiac output. Eur J Endocrinol. 1998 Apr;138(4):401-7.

  29. Lampit M, Hochberb Z. Prevention of Growth Deceleration after withdrawal of growth hormone therapy in idiopathic short stature. J Clin Endocrinol Metab. 2002 Aug;87(8):3573-7. 

  30. Pincelli AI, Bragato R, Scacchi M, et al. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD). J Endocrinol Invest. 2003 May;26(5):420-8

  31. Amato G, Mazziotti G, Di Somma C, et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.

  32. Micic D, Casabiell X, Gualillo O, Pombo M, Dieguez C, Casanueva FF. Growth hormone secretagogues: the clinical future. Horm Res. 1999;51 Suppl 3:29-33.

  33. Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, et al. Effect of cholinergic tone on growth hormone-releasing hormone-induced secretion of growth hormone in normal aging. Aging (Milano). 1992;4(3):231-7. 

  34.  eda GP, Ceresini G, Denti L, Marzani G, Piovani E, et al. alpha-Glycerylphosphorylcholine administration increases the GH responses to GHRH of young and elderly subjects. Horm Metab Res. 1992;24(3):119-21.

  35. Wang L, Pooler AM, Albrecht MA, Wurtman RJ. Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J Mol Neurosci. 2005;27(1):137-45.

Articles of Interest from Smart Publications Health & Wellness Update